Besins Healthcare S.A.

The US Food and Drug Administration’s newly revised stand on testosterone labeling for cardiovascular risk is the visible tip of the metaphorical iceberg of years of effort that went into evaluating a

AbbVie Inc. won another reprieve in AndroGel product liability litigation as a judge vacated a $140m jury verdict and ordered a new trial. It is the second bellwether trial in which the judge has f

While the Federal Trade Commission lost out on claims AbbVie Inc. engaged in a pay-for-delay deal, it won the overall battle with a court ruling that the company filed sham infringement suits agains

A new biotech established by Fortress Biotech Inc. will work to produce therapeutic advances in traumatic brain injury by reducing pro-inflammatory cytokines with a pair of stem cell therapy candi